Vitiligo Clinical Trials

26 recruiting

Vitiligo Trials at a Glance

38 actively recruiting trials for vitiligo are listed on ClinicalTrialsFinder across 6 cities in 35 countries. The largest study group is Phase 2 with 12 trials, with the heaviest enrollment activity in Indianapolis, Cairo, and Miami. Lead sponsors running vitiligo studies include Cairo University, Incyte Corporation, and University Hospital, Bordeaux.

Treatments under study

About Vitiligo Clinical Trials

Looking for clinical trials for Vitiligo? There are currently 26 studies actively recruiting participants. Clinical trials offer access to new treatments before they are widely available, and every approved therapy in use today was first tested through a clinical trial.

Below you can browse trials, sign up for alerts when new Vitiligo trials open, and view eligibility criteria for each study. Each listing includes the study phase, locations, and enrollment details.

Frequently Asked Questions

Common questions about Vitiligo clinical trials

A clinical trial is a carefully designed research study that tests new medical treatments, drugs, devices, or approaches in human volunteers. Every approved medication and treatment available today was proven safe and effective through clinical trials.

All clinical trials are reviewed and approved by Institutional Review Boards (IRBs) — independent committees that evaluate patient safety. Trials follow strict protocols, and your health is monitored closely throughout. You can withdraw at any time.

Not necessarily. Many trials compare the new treatment against the current standard of care, meaning all participants receive active treatment. When placebos are used, they are typically combined with standard treatment, not given alone. The trial description will always specify the design.

Under the Affordable Care Act, most private insurers are required to cover routine patient care costs during a clinical trial. The sponsor typically covers the investigational treatment itself. Medicare also covers routine costs for qualifying trials.

Yes. Participation is completely voluntary. You can withdraw at any time, for any reason, without it affecting your access to standard medical care.

Each trial has specific eligibility criteria — including age, diagnosis, disease stage, prior treatments, and general health. Browse the trials listed above and check their eligibility sections. You can also contact the trial site directly to discuss your situation.

Showing 120 of 38 trials

Recruiting
Phase 2

A Phase IIb Dose-ranging Study to Assess the Efficacy and Safety of GIA632 in Participants With Non-segmental Vitiligo

Non-segmental Vitiligo
Novartis Pharmaceuticals210 enrolled15 locationsNCT07431177
Recruiting
Phase 1

Study to Evaluate the Safety, Tolerability and How IBI3013 is Taken up and Processed by the Body in Healthy Volunteers After Single-dose Administration, and in Non-segmental Vitiligo Patients and Alopecia Areata Patients After Multiple-dose Administration

HealthySevere Alopecia AreataActive Non-segmental Vitiligo
Innovent Biologics (Suzhou) Co. Ltd.160 enrolled1 locationNCT07554222
Recruiting
Phase 2

A Study of LY4005130 in Adult Participants With Non-Segmental Vitiligo

VitiligoNon-Segmental Vitiligo (NSV)
Eli Lilly and Company60 enrolled35 locationsNCT07533019
Recruiting
Phase 2

Phase 2 Study to Evaluate EI-001 in Non-segmental Vitiligo Patients

Non-segmental Vitiligo
Elixiron Immunotherapeutics (Hong Kong) Ltd.45 enrolled3 locationsNCT07223229
Recruiting
Phase 4

The Value of Methotrexate in NCES for Stable Vitiligo

Vitiligo
Cairo University20 enrolled1 locationNCT07352293
Recruiting
Phase 4

Oral Mini Pulse Dexamethasone in Pediatric Vitiligo

Vitiligo
Cairo University22 enrolled1 locationNCT07353801
Recruiting
Phase 2

Melanotan II (MT-II) as an Adjunct to NB-UVB Phototherapy for Repigmentation in Stable Nonsegmental Vitiligo

NonSegmental VitiligoNonsegmental Vitiligo (Stable)
Hudson Biotech60 enrolled1 locationNCT07437560
Recruiting
Phase 2

A Trial of SHR0302 Tablets and SHR0302 Base Gel in Patients With Non-segmental Vitiligo

Non-segmental Vitiligo
Jiangsu HengRui Medicine Co., Ltd.176 enrolled1 locationNCT07251595
Recruiting

A Real World Study to Globally Assess Disease Burden in Adolescent and Adult Participants With Alopecia Areata, Vitiligo, or Hidradenitis Suppurativa

Alopecia AreataHidradenitis SuppurativaNon-Segmental Vitiligo (NSV)
AbbVie2,795 enrolled116 locationsNCT07136467
Recruiting
Early Phase 1

Effectiveness of Micro-needling With 5 Fluorouracil Versus Potent Topical Steroids in the Treatment of Limited Vitiligo

Vitiligo
Combined Military Hospital (CMH) institute of Medical Sciences Bahawalpur Pakistan40 enrolled1 locationNCT07398807
Recruiting
Not Applicable

PALLAS Laser for Skin Diseases

Alopecia AreataAtopic DermatitisPsoriasis+1 more
Szeged University50 enrolled1 locationNCT07250997
Recruiting
Phase 1

A Proof of Concept, Phase 1 Study of CGB-600 for the Topical Treatment of Non-Segmented Facial Vitiligo

Vitiligo
CAGE Bio Inc.36 enrolled2 locationsNCT07357870
Recruiting
Phase 4

Topical 5-Fluorouracil Effervescent Powder in the Treatment of Vitiligo

VitiligoTopical FluorouracilEffervescent Mixture
Al-Azhar University60 enrolled1 locationNCT05536856
Recruiting
Phase 2

Efficacy and Safety Phase II Study of VC005 Tablets in Subjects With Non-segmental Vitiligo

Non-segmental Vitiligo
Jiangsu vcare pharmaceutical technology co., LTD120 enrolled1 locationNCT07172347
Recruiting

A Real-world Study on the Influencing Factors of Efficacy of Ruxolitinib Cream in Vitiligo

Vitiligo
Peking University Third Hospital170 enrolled1 locationNCT07153666
Recruiting
Phase 3

A Study to Evaluate the Safety and Efficacy of Ruxolitinib Cream in Pediatric Participants With Nonsegmental Vitiligo

NonSegmental Vitiligo
Incyte Corporation180 enrolled99 locationsNCT06548360
Recruiting
Phase 3

A Study to Evaluate the Efficacy and Safety of Ruxolitinib Cream in Children (6 to < 12 Years Old) With Nonsegmental Vitiligo

NonSegmental Vitiligo
Incyte Corporation250 enrolled86 locationsNCT06804811
Recruiting
Phase 1

A Study of DR-01 in Subjects With Alopecia Areata and Vitiligo

Alopecia AreataVitiligo
Dren Bio80 enrolled20 locationsNCT06602232
Recruiting
Not Applicable

Betamethasone Phonophoresis For Vitiligo

Vitiligo
Cairo University60 enrolled1 locationNCT07267273
Recruiting
Phase 1

A Study to Evaluate the Safety and Efficacy of FB102 in Patients With Non-segmental Vitiligo

Vitiligo
Forte Biosciences, Inc.64 enrolled6 locationsNCT06905873